pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›iLution travoprost
drug · small molecule
save

iLution travoprost

Phase 2updated 5mo ago
by $GKOS GLAUKOS Corp🔗 ChEMBL
Phase 2
community read0 votes

🐶 often sniffed alongside

top 5
  • tagApproval42 co-mentions · 11 sources
  • drugIDOSE TR41 co-mentions · 11 sources
  • drugtravoprost ER41 co-mentions · 11 sources
  • drugTRAVATAN Z35 co-mentions · 11 sources
  • drugTRAVOPROST21 co-mentions · 11 sources

Small molecule drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 2 investigational indications.

targets

Prostaglandin F2-alpha receptor

all catalysts(0)

nothing on the calendar yet

Trials studying iLution travoprost

  • —iDose TR Administration in an Office-Based Surgery Settingrecruitingn=30
  • phase2Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implantrecruitingn=110
  • phase2A Study to Evaluate the Efficacy and Safety of OTX-TIC (Travoprost) Intracameral Implant for Patients With Open-angle Glaucoma (OAG) or Ocular Hypertension (OHT)completedn=83
  • phase4Travoprost Intraocular Implant + iStent Infiniterecruitingn=150
  • phase3Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implantrecruitingn=510
  • —Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcgrecruitingn=30
  • phase4Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alonerecruitingn=132
  • phase4Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucomarecruitingn=20

News(0)

no news has mentioned this drug yet

trade names
Idose tr, Izba, Travatan, Travatan z, Travoprost, Travoprost component of duotrav
generic
travoprost
MOA
Prostanoid FP receptor agonist
indication
Ocular Hypertension
phase
phase_2
Data sources
ClinicalTrials.gov · OpenTargets
last refreshed 1h ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?